We are live on
!
Find out more
GGHC
Gilder Gagnon Howe & Co Portfolio holdings
AUM
$8.34B
1-Year Est. Return
46.58%
This Fund
S&P 500
This Quarter
Est. Return
+5.42%
1 Year Est. Return
+46.58%
3 Year Est. Return
+191.6%
5 Year Est. Return
+200.35%
10 Year Est. Return
+3,561.44%
AUM
$7.98B
AUM Growth
-$21.8M
(-0.27%)
Cap. Flow
-$149M
Cap. Flow
% of AUM
-1.86%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
287
New
30
Increased
70
Reduced
150
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$82.6M |
| 2 |
EMBJ
Embraer S.A. ADS
EMBJ
|
+$56.2M |
| 3 |
BBB Foods
TBBB
|
+$39.9M |
| 4 |
Natera
NTRA
|
+$35.9M |
| 5 |
Loar Holdings
LOAR
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$171M |
| 2 |
NVIDIA
NVDA
|
+$107M |
| 3 |
Intel
INTC
|
+$54.3M |
| 4 |
Denali Therapeutics
DNLI
|
+$24.1M |
| 5 |
Netflix
NFLX
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.65% |
| 2 | Consumer Discretionary | 19.21% |
| 3 | Healthcare | 16.85% |
| 4 | Communication Services | 13.51% |
| 5 | Industrials | 6.67% |
Similar funds
MWM
AAF
NW
QC
VA
FT
OC
DM
Gilder Gagnon Howe & Co's Q2 2024 Portfolio in Review
As of Q2 2024, Gilder Gagnon Howe & Co held 287 positions worth $7.98B, down 0.27% from $8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Gilder Gagnon Howe & Co's Q2 2024 filing shows 30 new, 70 increased, 150 reduced and 36 closed positions. Its largest new stake was Boston Scientific: 1,128,740 shares worth $86.9M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $171M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Gilder Gagnon Howe & Co's largest Q2 2024 buy was Boston Scientific: 1,128,740 shares worth $86.9M.
- Gilder Gagnon Howe & Co added most to BBB Foods in Q2 2024, an estimated $39.9M increase.
- Gilder Gagnon Howe & Co's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $107M.
- Gilder Gagnon Howe & Co fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $171M.
- Gilder Gagnon Howe & Co's ten largest holdings make up 34% of its $7.98B portfolio in Q2 2024.
- Gilder Gagnon Howe & Co opened 30 new positions and closed 36 in Q2 2024.
- Gilder Gagnon Howe & Co's portfolio value fell 0.27% quarter-over-quarter to $7.98B.
Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2024, filed 14 Aug 2024.